Nachrichten zur AstraZeneca PLC Aktie

London’s New Listings Hit 28-Year Low as AstraZeneca Weighs Exit

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca…

Astrazeneca (AZN) Advances While Market Declines: Some Information for Investors

Astrazeneca (AZN) reached $71.46 at the closing of the latest trading day, reflecting a +2.26% change compared to its last…

Why AstraZeneca Stock Topped the Market on Tuesday

Trading in AstraZenecas (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to…

AstraZeneca boss ‘wants to shift stock market listing to US’

Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile…

AstraZeneca ‘may quit London stock market’

Pharma giant’s chief discusses shifting listing to US in potential blow to UK capital…

AstraZeneca reports total voting rights at over 1.55 billion shares By Investing.com

AstraZeneca reports total voting rights at over 1.55 billion shares…

AstraZeneca CEO eyes US market listing, The Times reports

AstraZeneca chief executive Pascal Soriot is considering moving the companys stock market listing to the United States, The Times reported…

AstraZeneca CEO wants to move Britain’s most valuable company to US

Sir Pascal Soriot is frustrated with restrictions on medicines by Nice and pricing under an NHS rebate scheme…

AstraZeneca: Navigating Challenges Across Geographies Well

…

IEFA Is a Great Choice for Most, but I Like VEA ETF Better

For investors in the United States, its pretty easy to get overexposed to domestic stocks. These are the brands that…

EQS-News: Attraktive Investmentperspektive: AstraZeneca zeigt Interesse an KI-Onkologie-Konsortium "PROmAI" (deutsch)

Attraktive Investmentperspektive: AstraZeneca zeigt Interesse an KI-Onkologie-Konsortium "PROmAI"^EQS-Media / 28.06.2025 / 14:56 CET/CESTOnco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco…

3 No-Brainer Stocks to Buy for Under $100 Right Now

Whats the biggest misconception about investing? The idea that you need a lot of money to get started is certainly…

EQS-News: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium (deutsch)

Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium^Emittent / Herausgeber: MCS Market…

Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium

Vancouver, Kanada - 27. Juni 2025 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" oder…

IRW-News: Onco-Innovations Limited: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-Konsortium

IRW-PRESS: Onco-Innovations Limited: Onco-Innovations begrüßt das Interesse von AstraZeneca an einer Gründungsrolle in PROmAI, einem von Inka angeführten KI-Onkologie-KonsortiumVancouver, Kanada…

Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

FDA Grants Label Expansion to AstraZenecas Datroway in Lung Cancer

FDA expands AstraZenecas Datroway label, making it the first TROP2-directed lung cancer therapy approved in the United States.…

ANALYSE-FLASH: JPMorgan belässt Astrazeneca auf 'Overweight' - Ziel 14000 Pence

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem…

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

3 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire

If youre looking for stocks that have the potential to make you a millionaire on a relatively modest investment, youre…

Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Astrazeneca (AZN) concluded the recent trading session at $73.55, signifying a -1.17% move from its prior days close.…

AstraZeneca enters into collaboration with CSPC

13 June 2025 AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research AstraZeneca has entered a strategic research collaboration with…

Astrazeneca (AZN) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Astrazeneca (AZN) settling at $73.83, representing a +1.12% change from its previous close.…

IonQ treibt die Anwendung der quantenbeschleunigten Arzneimittelentwicklung zusammen mit AstraZeneca, AWS und NVIDIA voran

COLLEGE PARK, Maryland--(BUSINESS WIRE)--IonQ (NYSE: IONQ), ein führendes Unternehmen in der Quantencomputer- und Netzwerkbranche, veröffentlichte heute Ergebnisse eines von IonQ,…

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Mercks shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.…

Is D-Wave Quantum a Better Quantum Computing Stock to Buy Than IonQ?

If everyone only invested in what they fully understood, I suspect quite a few stocks wouldnt exist today. We can…

AstraZeneca: Fascinating Company With Lofty Ambitions - Just Not A Buy Yet

…

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…

Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors

Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.…

Total Voting Rights

2 June 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds By Reuters

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds…

Danaher Partners With AstraZeneca to Support Precision Medicine

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making…

Why Tempus AI Stock Plummeted This Week

Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more…

Danaher in partnership with AstraZeneca for diagnostic tests for precision medicine

…

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today

Shares of Tempus AI (NASDAQ: TEM) are falling on Wednesday. One of Cathie Woods largest holdings, the companys stock plummeted…

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…

AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder Cancer

AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.…

Why AstraZeneca May Be 2025s Most Underrated Pharma Stock

…

Swedish Business Consortium to build AI Factory with NVIDIA

· AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments to tap new sovereign AI infrastructure · NVIDIA to open AI…

AstraZeneca CEO gains shares under performance plan By Investing.com

AstraZeneca CEO gains shares under performance plan…

The Zacks Analyst Blog Highlights Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust

Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust are part of the Zacks top Analyst Blog.…

dpa-AFX ProFeed